Inflammation, the acute phase response and atherosclerosis

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 5, 1999, Pages 495-503

  Whicher, John ^c   Biasucci, Luigi ^a   Rifai, Nader ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Rush House   (United Kingdom)

Author keywords

Acute phase response; Atherosclerosis; C reactive protein; Cardiovascular disease; Inflammation; Serum amyloid A protein

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CYTOKINE; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; HEART INFARCTION; HUMAN; INFLAMMATION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

ACUTE-PHASE REACTION; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CEREBROVASCULAR DISORDERS; HUMANS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN;

EID: 0033049957     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.080     Document Type: Review

References (89)

1. von den Velden R. Die Blutgerinnung nach parenteraler Zufuhr von Eiweisskörpern. Dtsch. Arch J Klin Med 1914; 41:298.
2. Fahraeus R. The suspension stability of the blood. Acta Med Scand 1921; 55:1-228.
3. Tillet WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumonococcus. J Exp Med 1930; 52:561-71.
4. Ash R. Non-specific precipitins of fraction C in acute infections. J Infect Dis 1933; 53:89-97.
5. Abernethy TJ, Avery OT. The occurrence during acute infection of a protein not normally present in blood. 1. Distribution of the reactive protein in patients sera and the effect of calcium on the flocculation reaction with the C polysaccharide of pneumococcus. J Exp Med 1941; 73:173-82.
6. MacLeod CM, Avery OT. The occurrence during acute infections of a protein not normally present in the blood. III Immunological properties of the C-reactive protein and its differentiation from normal blood proteins. J Exp Med 1941; 73:191-203.
7. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15:81-8.
8. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
9. Colley CM, Fleck A, Goode, AW, Muller, BR, Myers MA. Early time course of the acute phase protein response in man. J Clin Pathol 1983; 36:203-7.
10. Chambers RE, Hutton CW, Dieppe PA, Whicher JT. A comparative study of C reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis 1991; 50:677-9.
11. Whicher JT, Chambers RE, Higginson J, Nashef L, Higgins PG. Acute phase response of serum amyloid A protein and C-reactive protein to the common cold and influenza. J Clin Pathol 1985; 38:312-6.
12. Strachan AF, Noakes TD, Kotzenberg G, Nel AE, De Beer FC. C-reactive protein concentrations during long distance running. Br Med J 1984; 289:1249-54.
13. Das I Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985; 153:9-13.
14. Mortensen RF, Beisel K, Zelezik NJ, Le PT. Acute phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol 1983; 130:885-9.
15. Pepys MB, Baltz ML, Gomer K, Davies AS, Doenhoff M. Serum amyloid P component is an acute phase reactant in the mouse. Nature 1979; 278:259-61.
16. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993; 362:801-9.
17. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995; 91:2844-50.
18. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of TNF in human atheroma. Am J Cardiol 1989; 21:1241-51.
19. Kaartinen M, Penttila A, Kovanen P. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α. Circulation 1996; 94:2787-92.
20. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease: relevance in superoxide anion generation. Circulation 1994: 90:694-9.
21. Haught WH. Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB. Alterations in circulating intercellular adhesion molecule-I and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996; 132:1-8.
22. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule I and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351:88-92.
23. Mehta J, Dinerman J, Mehta P, Saldeen TG, Lawson D, Donnelly WH. Neutrophil function in ischemic heart disease. Circulation 1989; 79:549-56.
24. Friedman GD, Klatsky AL, Sieglaub AB. The leukocyte count as a predictor of acute myocardial infarction. N Engl J Med 1974; 290:1275-8.
25. Lowe GD, Machado SG, Krol WF, Barton BA, Forbes CD. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985; 54:700-3.
26. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of Interleukin-6 in unstable angina. Circulation 1996; 94:874-7.
27. Toss H, Lindahl B, Siegbahn A, Wallentin L. Fibrinogen is a prognostic marker independent of troponin T in unstable coronary artery disease (Abstr.). Circulation 1996; Suppl 1:322.
28. Neumann FJ, Katus HA, Hoberg E, Roebruck P, Braun M, Haupt HM, et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina. Br Heart J 1991; 66:425-30.
29. Mazzone A, De Servi S, Ricevuti G. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88:358-63.
30. Dinermain JL, Mehta JL, Saldeen TG, Emerson S, Wallin R, Davda R, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990; 15:1559-63.
31. Biasucci LM, D'Onofrio G, Liuzzo G, Zini G, Monaco C, Caligiuri, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996; 27:611-6.
32. Serneri GG, Abbate R, Gori AM. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86:790-7.
33. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 1998; 32:1295-304.
34. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98:2370-6.
35. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore IR, Caligiuri G, Lanza GA, et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996; 94:2373-80.
36. Biasucci LM, Liuzzo G, Caligiuri G, Vandegreef W, Quaranta G, Monaco C, et al. Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction. Am J Cardiol 1996; 77: 85-7.
37. Biasucci LM, Liuzzo G, Grillo RL, Cagliuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; in press.
38. Buja LM. Does atherosclerosis have an infectious etiology? Circulation 1996; 94:872-3.
39. Frothingham C. The relation between acute infectious diseases and arterial lesions. Arch Intern Med 1911; 8:153-62.
40. Ophuls W. Arteriosclerosis and cardiovascular disease: their relation to infectious diseases. JAMA 1921; 76:700-1.
41. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148:335-40.
42. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50:127-34.
43. Davies MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Eng J Med 1984; 310:1137-40.
44. Buffon A, Liuzzo G, D'Onofrio G. Intracardiac activation of neutrophils in unstable angina is unrelated to culprit coronary lesion (Abstr.). Circulation 1996; Suppl 1:514.
45. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-400.
46. Kuo CC, Shor A, Campbell L, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167:841-9.
47. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27:1555-61.
48. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994;42:170-4.
49. Wu TC, Hruban RH, Ambinder RF, Pizzoro M, Cameron DE, Baumgartner WA, et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 1992; 140:739-47.
50. Cook PJ, Lip GY. Infectious agents and atherosclerotic vascular disease. Q J Med 1996; 89:727-35.
51. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96:4095-103.
52. Saikku P, Leinonen M, Manila K, Ekman MR, Nieminen MS, Makela PH. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-6.
53. Dahlen GH, Boman J, Birgander LS, Lindblom B. Lp(a) lipoprotein, IgG. IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114:165-74.
54. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR. High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2:291-3.
55. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94:922-7.
56. Rasmussen SI. Eckmann L, Quayle AL, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99: 77-87.
57. Geist LJ, Dai LY. Cytomegalovirus modulated interleukin-6 gene expression. Transplantation 1996; 62:653-8.
58. Mendall MA, Goggin PM. Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71:437-9.
59. Patel P, Mendall MA, Carrington D, Strachan DP, Leathan E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4.
60. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74:497-501.
61. Pasceri V, Cammarota G, Patti G, Cuoco L. Gasbarrini A, Grillo RL, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998; 97:1675-9.
62. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312:1061-5.
63. Entman ML, Smith CW. Post-reperfusion inflammation: a model for reaction of injury in cardiovascular disease. Cardiovasc Res 1994; 28:1301-11.
64. de Beer FC, Hind CRK, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982; 47:239-43.
65. Kushner I, Broder ML, Karp D. Control of the acute phase response: serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978; 61:235-42.
66. Marhaug G, Harklau L, Olsen B, Husby G, Husebekk A, Wang H. Serum amyloid A protein in acute myocardial infarction. Acta Med Scand 1986; 220:303-6.
67. Maury CPJ, Totterman KJ, Gref C-G, Ehnholm C. Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction. J Clin Pathol 1988; 41:1263-8.
68. Shainkin-Kestenbaum R, Winikoff Y, Cristal N. Serum amyloid A concentrations during the course of acute ischaemic heart disease. J Clin Pathol 1986; 39:635-7.
69. Bausserman LL, Sadaniantz A, Saritelli AL, Martin VL, Nugent AM, Sady SP. Time course of serum amyloid A response in myocardial infarction. Clin Chim Acta 1989; 184:297-305.
70. Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ. Plasma plasminogen activator inhibitor-I in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis 1989; 9:362-7.
71. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J 1982; 47:239-43.
72. Berk BC, Weintraub WS, Alexander RW. Elevation ot C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990; 65:168-72.
73. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Eng J Med 1994; 331:417-424.
74. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Eng J Med 1995; 332:635-41.
75. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462-6.
76. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in myocardial infarction. J Am Cardiol 1998; 31:1460-5.
77. Ferreiros E, Boissonnet CP, Pizarro R, Garcia Merletti PF, Corrado A, Cagide A. Elevated C-reactive protein at discharge is a strong independent predictor of 90 day outcome in unstable angina (Abstr.). Circulation 1998; Suppl 1: 493-4.
78. Morrow DA, Antman EM, Rifai N, McCabe CH, Braunwald E. Serum amyloid A and rapid bedside Troponin T independently predict mortality in acute coronary syndromes (Abstr.). Circulation 1998; Suppl 1:493.
79. Rebuzzi AG, Quarante G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 1998; 82:715-9.
80. Mendall MA, Pratel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312:1061-5.
81. Kuller L, Tracy R, Shaten J, Meilahn E, for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144:537-47.
82. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-9.
83. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97:425-8.
84. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97:2007-11.
85. Koenig W, Froehlich M, Sund M, Doering A, Fischer H. Loewel H, et al. C-reactive protein (CRP) predicts risk of coronary heart disease (CHD) in healthy middle-aged men: results from the MONICA-Augsburg cohort study, 1984/85-1992 (Abstr.). Circulation 1997; Suppl 1:99.
86. Tracy R, Lemaitre R, Psaty B, Ives D, Evans R, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17:1121-7.
87. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998; 98:839-44.
88. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998; 35:745-53.
89. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-3.